Statistics for Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance.
Total visits
| views | |
|---|---|
| Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance. | 61 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| ARTIGO_ContinuousVersusGroup.pdf(legacy) | 9 |
| ARTIGO_ContinuousVersusGroup.pdf | 9 |
Top country views
| views | |
|---|---|
| Germany | 30 |
| United States | 30 |
| Netherlands | 13 |
| Vietnam | 12 |
| Brazil | 9 |
| China | 4 |
| Russia | 4 |
| United Kingdom | 3 |
| Singapore | 3 |
| Argentina | 2 |
| Poland | 2 |
| Austria | 1 |
| Portugal | 1 |
Top city views
| views | |
|---|---|
| Hanoi | 12 |
| Ashburn | 8 |
| Shenzhen | 3 |
| Santa Luzia | 2 |
| Ann Arbor | 1 |
| Fremont | 1 |
| Leawood | 1 |
| Mountain View | 1 |
| Niterói | 1 |
| Ribeirão Das Neves | 1 |
| Shanghai | 1 |
| São Paulo | 1 |
| Vienna | 1 |
| Washington | 1 |
| Wilmington | 1 |